A Phase I/II Study of CC-4047 [pamolidomide] in Combination With Gemcitabine in Subjects With Untreated Advanced Carcinoma of the Pancreas.

Trial Profile

A Phase I/II Study of CC-4047 [pamolidomide] in Combination With Gemcitabine in Subjects With Untreated Advanced Carcinoma of the Pancreas.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 24 Nov 2013

At a glance

  • Drugs Pomalidomide (Primary) ; Gemcitabine
  • Indications Pancreatic cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 02 May 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 02 May 2011 Actual end date (Jan 2011) added as reported by ClinicalTrials.gov.
    • 20 Jan 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top